Product Information
ETHOSUXIMIDE 250 MG CAPSULE is a generic product labeled by Epic Pharma LLC, priced at $0.2483 per EA under NDC 42806070801. Its NADAC has been published 167 times since Jun 14, 2023.
FDA first approved this application on Mar 16, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Epic Pharma LLCNDC
42806070801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ETHOSUXIMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210654FDA Approved
3/16/2020
TE Code
AB
On Market Since
11/12/2021
Pharmacological Classes
Price Statistics
The NADAC for ETHOSUXIMIDE 250 MG CAPSULE has been published 167 times since Jun 14, 2023, and over the history we have for it it has declined 34.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2483 per EA |
|---|---|
| All-time high | $0.3913 (Sep 13, 2023) |
| All-time low | $0.1798 (Nov 20, 2024) |
| 52-week high | $0.2595 |
| 52-week low | $0.2210 |
| Median price | $0.2569 |
| Average price | $0.2712 |
| Largest weekly change | +67.2% (Aug 21, 2024) |
| Weeks tracked | 167 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ETHOSUXIMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ETHOSUXIMIDE 250 MG CAPSULE, manufactured by Epic Pharma LLC, is $0.2483 per EA (NDC 42806070801), effective Aug 19, 2026.
How has the price of ETHOSUXIMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has declined 34.1%. It has been tracked across 167 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for ETHOSUXIMIDE 250 MG CAPSULE?
Since Jun 14, 2023, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has ranged from a low of $0.1798 (Nov 20, 2024) to a high of $0.3913 (Sep 13, 2023), with a median of $0.2569 per EA.
Are there cheaper alternatives to ETHOSUXIMIDE 250 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETHOSUXIMIDE 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ETHOSUXIMIDE 250 MG CAPSULE?
ETHOSUXIMIDE 250 MG CAPSULE (NDC 42806070801) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.